Oncology Impact Fund (Cayman) Management L.P., 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 88,716 shares at $29.09 ($2.6M) on 2021-08-27, disclosed to the SEC on 2021-08-31.
Scheduled sale ($2.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.09 | 13,357 | $389K | 15.0% |
| 2 | $29.09 | 13,357 | $389K | 15.0% |
| 3 | $29.30 | 31,001 | $908K | 35.0% |
| 4 | $29.30 | 31,001 | $908K | 35.0% |
| Total | $29.24 avg | 88,716 | $2.6M | 100% |
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |